Key result
Continuous monitoring with an implantable loop recorder detected atrial fibrillation in 41% of patients with end-stage kidney disease on maintenance hemodialysis over a median of 177 days.
Answers are grounded in this paper and cite their sources.
Highlights that the prevalence of atrial fibrillation is likely underestimated in hemodialysis patients and emphasizes its role as a stroke risk factor.
The incidence of atrial fibrillation (AF) is increased in individuals with chronic kidney disease with the highest risk in those with end-stage kidney disease (ESKD).1 This relationship is unsurprising given shared risk factors for AF and chronic kidney disease, including older age, hypertension, and vascular disease. Current data almost certainly underestimate the true prevalence of AF in the hemodialysis population. Asymptomatic, “subclinical,” short-duration AF lasting >6 minutes has been recognized as a risk factor for stroke in the general population.
No takes yet. Share an insight, caveat, or question.
Law et al. (2021) conducted an editorial in End-stage kidney disease on maintenance hemodialysis (n=66). Implantable loop recorder (ILR) monitoring was evaluated on ILR-detected atrial fibrillation. Continuous monitoring with an implantable loop recorder detected atrial fibrillation in 41% of patients with end-stage kidney disease on maintenance hemodialysis over a median of 177 days.
Synapse has enriched 10 related papers. Consider them for comparative context: